Virus detection via programmable Type III-A CRISPR-Cas systems.
Virus detection via programmable Type III-A CRISPR-Cas systems.
复制标题
通过可编程III-A型CRISPR-Cas系统进行病毒检测。
DOI:
10.1038/s41467-021-25977-7
复制
发表时间:
2021-09-27
影响因子:
16.6
通讯作者:
Li H
中科院分区:
文献类型:
--
作者:
Sridhara S;Goswami HN;Whyms C;Dennis JH;Li H
Among the currently available virus detection assays, those based on the programmable CRISPR-Cas enzymes have the advantage of rapid reporting and high sensitivity without the requirement of thermocyclers. Type III-A CRISPR-Cas system is a multi-component and multipronged immune effector, activated by viral RNA that previously has not been repurposed for disease detection owing in part to the complex enzyme reconstitution process and functionality. Here, we describe the construction and application of a virus detection method, based on an in vivo-reconstituted Type III-A CRISPR-Cas system. This system harnesses both RNA- and transcription-activated dual nucleic acid cleavage activities as well as internal signal amplification that allow virus detection with high sensitivity and at multiple settings. We demonstrate the use of the Type III-A system-based method in detection of SARS-CoV-2 that reached 2000 copies/μl sensitivity in amplification-free and 60 copies/μl sensitivity via isothermal amplification within 30 min and diagnosed SARS-CoV-2-infected patients in both settings. The high sensitivity, flexible reaction conditions, and the small molecular-driven amplification make the Type III-A system a potentially unique nucleic acid detection method with broad applications. CRISPR-Cas based virus detection assays can be both rapid and sensitive. Here the authors use a Type III-A CRISPR-Cas system to detect SARS-CoV-2.
登录
查看更多内容
DOI:
10.1126/science.aaf5573
发表时间:
2016-08-05
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Abudayyeh OO;Gootenberg JS;Konermann S;Joung J;Slaymaker IM;Cox DB;Shmakov S;Makarova KS;Semenova E;Minakhin L;Severinov K;Regev A;Lander ES;Koonin EV;Zhang F
通讯作者:
Zhang F
DOI:
10.1016/s2213-2600(21)00005-9
发表时间:
2021-03
期刊:
The Lancet. Respiratory medicine
影响因子:
--
作者:
Kirby T
通讯作者:
Kirby T
影响因子:
33.5
作者:
Li SY;Cheng QX;Wang JM;Li XY;Zhang ZL;Gao S;Cao RB;Zhao GP;Wang J
通讯作者:
Wang J
影响因子:
11.8
作者:
Fauci AS;Touchette NA;Folkers GK
通讯作者:
Folkers GK
影响因子:
16.6
作者:
Ding X;Yin K;Li Z;Lalla RV;Ballesteros E;Sfeir MM;Liu C
通讯作者:
Liu C